Cardiovascular Diseases Research in California
Cardiovascular Diseases Research (93.837) awarded $1.8 billion to recipients in California in 1,464 grants from fiscal 2021 to 2025, 12% of the program's national total. The Leland Stanford Junior University received the most, $310 million.
- Awarded in California$1.8 billion
- Awards1,464
- Share of the program12%
- Rank among states1st of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 702 | $356 million |
| FY 2022 | 742 | $378 million |
| FY 2023 | 705 | $360 million |
| FY 2024 | 707 | $360 million |
| FY 2025 | 690 | $379 million |
Recipients in California
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Leland Stanford Junior University | Colleges and universities | 269 | $310 million |
| The Regents of the University of California, San Francisco | Colleges and universities | 251 | $304 million |
| University of California, San Diego | Colleges and universities | 193 | $249 million |
| University of California, Los Angeles | Colleges and universities | 160 | $221 million |
| Cedars-Sinai Medical Center | Nonprofits | 83 | $125 million |
| University of California, Davis | Colleges and universities | 75 | $90.5 million |
| University of Southern California | Colleges and universities | 48 | $67.0 million |
| Scripps Research Institute | Nonprofits | 20 | $49.7 million |
| Kaiser Foundation Hospitals | Nonprofits | 28 | $46.6 million |
| University of California Irvine | Colleges and universities | 35 | $45.0 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to California?
$1.8 billion from fiscal 2021 to 2025, across 1,464 awards. California ranks 1st of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in California?
The largest recipient is The Leland Stanford Junior University, with $310 million in 269 awards. Next are The Regents of the University of California, San Francisco and University of California, San Diego.
Can organizations in California apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in California
- Grants to States for Medicaid
- Education Stabilization Fund
- Highway Planning and Construction
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Federal Transit Formula Grants
- Title I Grants to Local Educational Agencies
- Head Start